WALGREENS BOOTS ALLIANCE INC shareholders Q2 2023

WALGREENS BOOTS ALLIANCE INC's ticker is WBA and the CUSIP is 931427108. A total of 1,123 filers reported holding WALGREENS BOOTS ALLIANCE INC in Q2 2023. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

WALGREENS BOOTS ALLIANCE INC shareholders Q2 2023
NameSharesValueWeighting ↓
RAYMOND JAMES & ASSOCIATES 10,000$250,0000.00%
HighTower Advisors, LLC 5$850.00%
JONES FINANCIAL COMPANIES LLLP 5,457$155,4700.00%
HAP Trading, LLC 19,100$2,1270.00%
Schonfeld Strategic Advisors LLC 50,000$1,0000.00%
THOMPSON SIEGEL & WALMSLEY LLC 250$70.00%
EARNEST PARTNERS LLC 370$10,5410.00%
About WALGREENS BOOTS ALLIANCE INC

Walgreens Boots Alliance Inc. is a global pharmacy-led health and wellbeing company that operates in more than 25 countries. The company is headquartered in Deerfield, Illinois, and has a market capitalization of over $50 billion. Walgreens Boots Alliance operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale.

The Retail Pharmacy USA segment includes the Walgreens brand, which is the largest drugstore chain in the United States. The segment also includes the company's specialty pharmacy and retail healthcare clinics. The Retail Pharmacy International segment includes the Boots brand, which is a leading pharmacy-led health and beauty retailer in the United Kingdom and other countries. The Pharmaceutical Wholesale segment includes the company's wholesale and distribution businesses.

Walgreens Boots Alliance has been expanding its business through strategic partnerships and acquisitions. In 2018, the company acquired a 40% stake in Sinopharm Holding Guoda Drugstores Co. Ltd., which is one of the largest pharmacy chains in China. The company has also partnered with Kroger, one of the largest grocery store chains in the United States, to create a new retail concept that combines grocery and pharmacy services.

Despite the challenges posed by the COVID-19 pandemic, Walgreens Boots Alliance has continued to perform well. In the third quarter of 2021, the company reported a 12.1% increase in sales compared to the same period in the previous year. The company's strong performance can be attributed to its focus on providing essential healthcare services and products to customers around the world.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists WALGREENS BOOTS ALLIANCE INC's shareholders in Q2 2023. To view WALGREENS BOOTS ALLIANCE INC's shareholder history, click here.